A detailed history of Creative Planning transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Creative Planning holds 6,143 shares of HRMY stock, worth $254,873. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,143
Holding current value
$254,873
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$30.0 - $39.95 $184,290 - $245,412
6,143 New
6,143 $245,000
Q3 2023

Nov 16, 2023

BUY
$31.89 - $39.03 $2,359 - $2,888
74 New
74 $2,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.45B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.